{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T12:28:23Z","timestamp":1707913703319},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1726,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1111\/j.1442-2050.2010.01145.x","type":"journal-article","created":{"date-parts":[[2010,12,10]],"date-time":"2010-12-10T21:11:27Z","timestamp":1292015487000},"page":"330-336","source":"Crossref","is-referenced-by-count":5,"title":["Toxicity data for preoperative concurrent chemoradiotherapy with oxaliplatin and continuous infusion 5-fluorouracil for locally advanced esophageal cancer"],"prefix":"10.1093","volume":"24","author":[{"given":"A.","family":"Thukral","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Metz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.-T.","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"O'Dwyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Plastaras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Both","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. Bar","family":"Ad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2010,12,10]]},"reference":[{"key":"10.1111\/j.1442-2050.2010.01145.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"10.1111\/j.1442-2050.2010.01145.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ijc.11029","article-title":"Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas","volume":"105","author":"Polednak","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1111\/j.1442-2050.2010.01145.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1245\/ASO.2004.10.026","article-title":"Controversies in the multimodality management of locally advanced esophageal cancer: evidence-based review of surgery alone and combined-modality therapy","volume":"11","author":"Iyer","year":"2004","journal-title":"Ann Surg Oncol"},{"key":"10.1111\/j.1442-2050.2010.01145.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1470-2045(07)70039-6","article-title":"Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis","volume":"8","author":"Gebski","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1111\/j.1442-2050.2010.01145.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1200\/JCO.2007.12.9593","article-title":"Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781","volume":"26","author":"Tepper","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1442-2050.2010.01145.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1055-3207(02)00013-3","article-title":"Combined modality therapy of esophageal cancer-standard of care?","volume":"11","author":"Urba","year":"2002","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1111\/j.1442-2050.2010.01145.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJM199608153350702","article-title":"A comparison of multimodal therapy and surgery for esophageal adenocarcinoma","volume":"335","author":"Walsh","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1442-2050.2010.01145.x-BIB8|cit8","first-page":"97","article-title":"New developments in the treatment of esophageal cancer","volume":"2","author":"Ilson","year":"2004","journal-title":"Clin Adv Hematol Oncol"},{"issue":"2","key":"10.1111\/j.1442-2050.2010.01145.x-BIB9|cit9","first-page":"13","article-title":"Pharmacokinetics and safety profile of oxaliplatin","volume":"25","author":"Extra","year":"1998","journal-title":"Semin Oncol"},{"key":"10.1111\/j.1442-2050.2010.01145.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0360-3016(02)02933-4","article-title":"Radiochemotherapy with short daily infusion of low-dose oxaliplatin, leucovorin, and 5-FU in T3-T4 unresectable rectal cancer: a phase II IATTGI study","volume":"54","author":"Carraro","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1111\/j.1442-2050.2010.01145.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2000.18.16.2938","article-title":"Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer","volume":"18","author":"de Gramont","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1442-2050.2010.01145.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1200\/JCO.2001.19.9.2433","article-title":"Addition of oxaliplatin to continuous fluorouracil, l-folinic acid, and concomitant radiotherapy in rectal cancer: the Lyon R 97-03 phase I trial","volume":"19","author":"Freyer","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1442-2050.2010.01145.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1200\/JCO.2006.08.2974","article-title":"Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07","volume":"25","author":"Kuebler","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1442-2050.2010.01145.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1200\/JCO.2002.12.032","article-title":"Oxaliplatin in combination with protracted-infusion fluorouracil and radiation: report of a clinical trial for patients with esophageal cancer","volume":"20","author":"Khushalani","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1442-2050.2010.01145.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/PPO.0b013e318046ee1a","article-title":"Concurrent oxaliplatin, 5-fluorouracil, and radiotherapy in the treatment of locally advanced esophageal carcinoma","volume":"13","author":"O'Connor","year":"2007","journal-title":"Cancer J"},{"key":"10.1111\/j.1442-2050.2010.01145.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00280-008-0834-3","article-title":"Multi-center phase II trial of chemo-radiotherapy with 5-fluorouracil, leucovorin and oxaliplatin in locally advanced esophageal cancer","volume":"63","author":"Chiarion-Sileni","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1111\/j.1442-2050.2010.01145.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa073149","article-title":"Capecitabine and oxaliplatin for advanced esophagogastric cancer","volume":"358","author":"Cunningham","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1442-2050.2010.01145.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1200\/JCO.2007.13.9378","article-title":"Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie","volume":"26","author":"Al-Batran","year":"2008","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1111\/j.1442-2050.2010.01145.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0360-3016(99)90220-1","article-title":"Oxaliplatin: in vitro evidence of its radiation sensitizing activity - preclinical observations relevant to clinical trials (Abstract 202)","volume":"45","author":"Blackstock","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1111\/j.1442-2050.2010.01145.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10637-008-9178-4","article-title":"A phase II trial of chemoradiation therapy with weekly oxaliplatin and protracted infusion of 5-fluorouracil for esophageal cancer","volume":"27","author":"Burmeister","year":"2009","journal-title":"Invest New Drugs"},{"key":"10.1111\/j.1442-2050.2010.01145.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1111\/j.1572-0241.2007.01437.x","article-title":"Baseline nutritional status is predictive of response to treatment and survival in patients treated by definitive chemoradiotherapy for a locally advanced esophageal cancer","volume":"102","author":"Di Fiore","year":"2007","journal-title":"Am J Gastroenterol"}],"container-title":["Diseases of the Esophagus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1442-2050.2010.01145.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/dote\/article-pdf\/24\/5\/330\/10396004\/dote0330.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T00:05:06Z","timestamp":1559865906000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/dote\/article-lookup\/doi\/10.1111\/j.1442-2050.2010.01145.x"}},"subtitle":["5-FU and oxaliplatin in esophageal cancer"],"short-title":[],"issued":{"date-parts":[[2010,12,10]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1442-2050.2010.01145.x","relation":{},"ISSN":["1120-8694"],"issn-type":[{"value":"1120-8694","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12,10]]}}}